CD274 / PDL1 (Fc portion) Human Protein
CAT#: AR31199PU-S
CD274 / PDL1 (Fc portion) human recombinant protein, 20 µg
Need it in bulk or customized? Get a free quote |
CNY 3,380.00
货期*
7周
规格
Cited in 5 publications. |
Product images
Specifications
Product Data | |
Species | Human |
Expression Host | CHO |
Expression cDNA Clone or AA Sequence |
Monomer:
FTVTVPKDLY VVEYGSNMTI ECKFPVEKQL DLAALIVYWE MEDKNIIQFV HGEEDLKVQH SSYRQRARLL KDQLSLGNAA LQITDVKLQD AGVYRCMISY GGADYKRITV KVNAPYNKIN QRILVVDPVT SEHELTCQAE GYPKAEVIWT SSDHQVLSGK TTTTNSKREE KLFNVTSTLR INTTTNEIFY CTFRRLDPEE NHTAELVIPE LPLAHPPNER GGPKSCDKTH TCPPCPAPEL LGGPSVFLFP PKPKDTLMIS RTPEVTCVVV DVSHEDPEVK FNWYVDGVEV HNAKTKPREE QYNSTYRVVS VLTVLHQDWL NGKEYKCKVS NKALPAPIEK TISKAKGQPR EPQVYTLPPS RDELTKNQVS LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSKLTVDK SRWQQGNVFS CSVMHEALHN HYTQKSLSLS PGK |
Predicted MW | 102.6 kDa |
Purity | >95% pure by SDS-PAGE and HPLC analyses |
Buffer | Presentation State: Purified State: Lyophilized (sterile filtered) purified protein Buffer System: 10 mM Sodium Phosphate + 25 mM NaCl, pH 7.6 |
Preparation | Lyophilized (sterile filtered) purified protein |
Protein Description | CHO cell-derived Recombinant Human PD-L1 Fc is a glycosylated, disulfide-linked homodimer of 906 amino acid residues whose monomer consists of the 220-amino-acid length extracellular portion of PD-L1 fused to the 231-amino-acid length Fc portion of human IgG1 by two glycines. The calculated molecular weight of CHO cell-derived Recombinant Human PD-L1 Fc is 102.6 kDa, however, due to glycosylation, it migrates at an apparent molecular weight of approximately 160-170 kDa by SDS-PAGE analysis under non-reducing conditions. |
Note | Centrifuge the vial prior to opening! |
Storage | Store lyophilized at 2-8°C for 6 months or at -20°C long term. After reconstitution store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C long term. Avoid repeated freezing and thawing. |
Stability | Shelf life: one year from despatch. |
Bioactivity | Biological: Determined by its ability to induce adhesion in T-cell enriched PBMC cultures. The ED50 for this effect is 1.2-2.0 μg/ml. |
Endotoxin | < 0.1 ng per µg (1EU/µg) |
Reference Data | |
RefSeq | NP_001254635 |
Locus ID | 29126 |
UniProt ID | Q9NZQ7 |
Cytogenetics | 9p24.1 |
Synonyms | PD-L1, PDCD1 ligand 1, B7H1, B7H1, B7 homolog 1, PDCD1L1, PDCD1LG1 |
Summary | This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015] |
Protein Families | Druggable Genome, Transmembrane |
Protein Pathways | Cell adhesion molecules (CAMs) |
Citations (5)
The use of this Proteins has been cited in the following citations: |
---|
Phage display-identified PD-L1-binding peptides reinvigorate T-cell activity and inhibit tumor progression.
,null,
Biomaterials
,PubMed ID 32278214
[CD274]
|
Identification and characterization of an alternative cancer-derived PD-L1 splice variant
,null,
Cancer immunology, immunotherapy : CII
,PubMed ID 30564890
[CD274]
|
PD‐L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation
,null,
International Journal of Cancer
,PubMed ID 28614911
[CD274]
|
Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition
,null,
The Journal of Clinical Investigation
,PubMed ID 27454297
[CD274]
|
Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells
,null,
Molecular Cancer
,PubMed ID 26245467
[CD274]
|
Documents
FAQs |
SDS |
Customer
Reviews
Loading...